Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Campani C, Shim JH, Bouattour M, Touchefeu Y, Delhoume V, Rosmorduc O, Pascale A, An J, Lee HC, Regnault H, Thabut D, Amaddeo G, Ningarhari M, Ollivier-Hourmand I, Métivier C, Ronot M, Ntandaja-Wandji L, Ozenne V, Sidali S, Marra F, Hollande C, Ganne-Carrié N, Nahon P, Peron JM, Lequoy M, Sharma R, Paris Liver Cancer Group, Allaire M, Nault JC

Open source

DOI
10.1158/1078-0432.ccr-25-4943
Published
2026 Jul 17
Container
Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-4943,
  title = {Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.},
  author = {Campani C and Shim JH and Bouattour M and Touchefeu Y and Delhoume V and Rosmorduc O and Pascale A and An J and Lee HC and Regnault H and Thabut D and Amaddeo G and Ningarhari M and Ollivier-Hourmand I and Métivier C and Ronot M and Ntandaja-Wandji L and Ozenne V and Sidali S and Marra F and Hollande C and Ganne-Carrié N and Nahon P and Peron JM and Lequoy M and Sharma R and Paris Liver Cancer Group and Allaire M and Nault JC},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-4943},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-4943}
}

RIS

TY  - JOUR
TI  - Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.
AU  - Campani C
AU  - Shim JH
AU  - Bouattour M
AU  - Touchefeu Y
AU  - Delhoume V
AU  - Rosmorduc O
AU  - Pascale A
AU  - An J
AU  - Lee HC
AU  - Regnault H
AU  - Thabut D
AU  - Amaddeo G
AU  - Ningarhari M
AU  - Ollivier-Hourmand I
AU  - Métivier C
AU  - Ronot M
AU  - Ntandaja-Wandji L
AU  - Ozenne V
AU  - Sidali S
AU  - Marra F
AU  - Hollande C
AU  - Ganne-Carrié N
AU  - Nahon P
AU  - Peron JM
AU  - Lequoy M
AU  - Sharma R
AU  - Paris Liver Cancer Group
AU  - Allaire M
AU  - Nault JC
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-25-4943
UR  - https://doi.org/10.1158/1078-0432.ccr-25-4943
ER  - 

APA

C, C., JH, S., M, B., Y, T., V, D., O, R., A, P., J, A., HC, L., H, R., D, T., G, A., M, N., I, O., C, M., M, R., L, N., V, O., S, S., F, M., C, H., N, G., P, N., JM, P., M, L., R, S., Group, P. L. C., M, A., & JC, N. (2026). Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4943

Source records